No regulatory approvals required for cell therapy use.
Many uses besides diabetes. A platform technology.
Day surgery only to install graft under a local anaesthetic.
A very strong hint that PNV will be involved in future funding and possible acquisition.
I think we will hear more about that sooner that later.
A lot to like about that presentation.
No regulatory approvals required for cell therapy use. Many uses...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.008(0.63%) |
Mkt cap ! $827.2M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.21 | $1.17 | $491.4K | 414.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 22918 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 6596 | 11 |
View Market Depth
| Last trade - 10.59am 24/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |